Records containing: Pulmonary Vascular Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-19Clinical Implications of Pulmonary Vascular Disease in Valvular Heart Disease
-
CLINICAL_TRIALS study record update · 2026-03-05Comparison of Noninvasively-Obtained Echocardiographic Doppler Parameters With Simultaneously-Measured Invasive Hemodynamics in Patients Referred for Right Heart Catheterization
-
CLINICAL_TRIALS study record update · 2025-08-14Assessment of Pulmonary Blood Volume Using Contrast Echocardiography During Exercise
-
CLINICAL_TRIALS study record update · 2025-03-13Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
-
CLINICAL_TRIALS study record update · 2023-10-23Comparative Study of Pulmonary Artery Pressure (PAP) and Other Hemodynamics Assessed by Echocardiography in Patients With Pulmonary Vascular Diseases Permanently Residing Above 2500 Meters When Assessed Near Resident High Altitude (HA) at 2840m vs. at Low Altitude (LA) Sea Level
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-10-18Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI
-
CLINICAL_TRIALS study record update · 2023-10-10Comparative Study of Sleep Disordered Breathing (SDB) in Patients With Pulmonary Vascular Diseases Permanently Residing Above 2500 Meters When Assessed Near Resident High Altitude (HA) at 2840m vs. at Low Altitude (LA) Sea Level
-
CLINICAL_TRIALS study record update · 2023-10-05Effect of Supplemental Oxygen Therapy (SOT) in Patients With Pulmonary Vascular Diseases (PVD) Defined as Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension (PH) Who Permanently Live >2500m on 6-minute Walk Distance (6MWD)
-
CLINICAL_TRIALS study record update · 2023-10-03Comparative Study of 6-minute Walk Distance (6MWD) in Patients With Pulmonary Vascular Diseases Permanently Residing Above 2500 Meters When Assessed Near Resident High Altitude (HA) at 2840m vs. at Low Altitude (LA) Sea Level.
-
CLINICAL_TRIALS study record update · 2022-02-22Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging
-
CLINICAL_TRIALS study record update · 2017-05-05Ad Hoc Analysis for the Evaluation of Dynamic Pulmonary Vascular Resistance in Patients With a Closed Ventricular Septal Defect
-
CLINICAL_TRIALS study record update · 2012-06-08A Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study of an Anti-human-T-lymphocyte Immune Globulin (EZ-2053) in the Prophylaxis of Acute Pulmonary Allograft Rejection in Adult Recipients of Primary Pulmonary Allograft(s)